# Sodium Phenylacetate and Sodium Benzoate

NDC: 70511-102
Generic name: Sodium Phenylacetate and Sodium Benzoate
Labeler / Manufacturer: MAIA PHARMACEUTICALS
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20210701

FDA application: NDA215025

## Active ingredients

- SODIUM BENZOATE: 100 mg/mL
- SODIUM PHENYLACETATE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab40b62b-9f8d-4394-92d5-09d9f1941eaa